firms mullen-mullen-law-firm 
FDA Law Blog
MARCH 19, 2024
(HP&M), the largest dedicated food and drug law firm in the U.S., is pleased to announce that Director Allyson Mullen has been appointed to the Board of Directors of the Association of Medical Diagnostic Manufacturers (AMDM). Mullen expressed her enthusiasm: “I am honored to join the AMDM Board of Directors.
FDA Law Blog
NOVEMBER 15, 2023
(“HP&M”) is proud to announce the firm has been selected to the 2 024 edition of Best Law Firms. Firms included in the 2024 Best Law Firms ranking are recognized for professional excellence with persistently impressive ratings from clients and peers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SCOTUSBlog
MAY 3, 2022
Court of Appeals for the 1st Circuit, kicked off the tributes by listing a few of the justice’s accomplishments: “He was a war hero, a pilot, a superstar law student, an accomplished tennis player, and – I can attest from personal observation – an average golfer.” David Baron, the chief judge of the U.S.
Diane Drain
APRIL 16, 2022
SHOULD THE LAW CHANGE? Current state law precludes debtors like the Hebenthals from receiving tax refunds if they recently filed for bankruptcy before getting the funds. Neeley, whose firm is representing the Hebenthals, said he supports the measure as a means to give debtors a fresh financial start. Brian Mullen.
The Fashion Law
OCTOBER 5, 2021
As the story goes, the then-35-year old Arnault – who had spent the previous 10 years heading up the construction firm founded by his grandfather – took $15 million from his family, combined it with $45 million from French financial institution Lazard Frères, and purchased Boussac in a quest to get his hands on the famed French fashion house.
FDA Law Blog
JUNE 27, 2023
We are proud as a firm of this honor and would also like to extend congratulations to all of this year’s Law360 Rising Stars! Mr. Karst, a co-author of the FDA Law Blog, provides regulatory counsel to pharmaceutical manufacturers on Hatch-Waxman patent and exclusivity, drug development, pediatric testing, and orphan drugs.
Expert insights. Personalized for you.
59 
Let's personalize your content